Carnosine eye drops: To prevent your eyes from senile cataracts
Carnosine eye drops: To prevent your eyes from senile cataracts
The can-c brand is approved and patented by Innovative Vision Products (IVP) who is the inventors of this unique technology.
IVP are a US based bio-engineering company that operates in Russia and have utilized Russian scientists and researchers to develop a unique form of carnosine known as n-acetylcarnosine (NAC). NAC has been proven to be a highly effective non-surgical treatment for senile cataracts.
Can-C is the only original and approved cataract eye drops that have been trialed and tested and contain natural dipeptide n-acetylcarnosine.
Dr Mark Babizhayev (Can-C inventor at IVP) believes that the granting of this patent means recognition for all their efforts in studying and testing which proved can-c eye drops were effective and of great importance to the aging community.
Statistics in the USA have shown 1.35 million cataract operations each year with many people often requiring further laser treatment along with having to adapt in coping with the new artificial lenses. These carnosine eye drops are a safe and effective non-surgical way of treating cataracts.
As expected many in the international market have taken the opportunity to benefit from this breakthrough product. As a result they have started to offer similar products that produce poor results. These products do not offer IVP's proprietary N-acetylcarnosine formulation however often make reference to it.
Fortunately there is a straightforward method to establish whether the purchase is the clinically proven formula. Each box has the following printed statement "Approved by Innovative Vision Products (IVP)."
One study carried out by Dr Barbizhayev and co workers involved 110 eyes. 60 of these eyes were given the can-c eye drop treatment twice daily. 30 of the eyes were given a placebo eye drop and the remaining 20 eyes received no treatment. The evaluation took place firstly at the start of the study and then at 2 monthly intervals for a period of 6 months.
It was discovered that after six month treatment 96% of the treated eyes showed amazing improvement with the vast result being in those eyes that had suffered age related cataracts. The study also revealed an effect that is known as the "melting snow" (the break-up of impaired proteins that cause cataracts). Within 1 months use the treatment could be observed with the affected lenses gradually becoming more transparent.
These results demonstrate incredible effects and the fact that up until now the only treatment available for cataracts was surgery. Now there really is an alternative.